Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EROS: Biweekly vs Triweekly TOMOX in First-line Metastatic Colorectal Cancer
NCT02821559Phase 2Completed
- Sponsor
- CHU de Besançon
- Start
- Aug 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltitrexed, oxaliplatin in colorectal cancer (CRC), sponsored by CHU de Besançon. Started Aug 2012; status: completed.
02
Drugs
raltitrexedoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02821559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02821559.